Silk Road Medical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017
Market Capitalization	761	478	2,015	1,487	2,139	1,246	-	-
Market Cap Growth	-	-76.28%	35.50%	-30.48%	71.60%	-	-	-
Enterprise Value	655	372	1,876	1,425	2,039	1,200	19	-6
PE Ratio	-8.57	-8.57	-36.63	-29.85	-45.19	-23.78	-	-
PS Ratio	4.30	2.70	14.53	14.65	28.43	19.67	-	-
PB Ratio	5.03	3.16	12.30	18.77	19.90	17.34	-	-
P/FCF Ratio	-14.26	-14.26	-53.60	-34.03	-49.84	-41.35	-	-
P/OCF Ratio	-14.93	-14.93	-61.84	-38.19	-50.84	-42.09	-	-
EV/Sales Ratio	3.70	2.10	13.53	14.04	27.11	18.94	0.55	-0.44
EV/EBITDA Ratio	-8.25	-8.25	-40.12	-31.41	-49.11	-26.00	-0.58	0.41
EV/EBIT Ratio	-7.61	-7.61	-37.58	-30.13	-47.52	-25.29	-0.57	0.41
EV/FCF Ratio	-11.10	-11.10	-49.90	-32.62	-47.53	-39.82	-0.79	0.24
Debt / Equity Ratio	0.50	0.50	0.46	0.61	0.45	0.62	-0.33	-0.28
Debt / EBITDA Ratio	-1.68	-1.68	-1.60	-1.07	-1.17	-0.97	-1.35	-1.81
Debt / FCF Ratio	-2.26	-2.26	-1.98	-1.11	-1.13	-1.49	-1.84	-1.07
Quick Ratio	6.77	6.77	9.47	4.69	8.02	5.88	2.96	8.39
Current Ratio	7.95	7.95	10.41	5.49	8.86	6.64	3.60	9.04
Asset Turnover	0.68	0.68	0.75	0.62	0.44	0.55	0.81	-
Interest Coverage	-7.11	-7.11	-9.79	-18.78	-9.73	-9.58	-7.63	-3.91
Return on Equity (ROE)	-36.10%	-36.10%	-63.10%	-54.60%	-45.30%	-277.20%	32.30%	-
Return on Assets (ROA)	-21.30%	-21.30%	-29.80%	-30.20%	-27.90%	-45.80%	-87.70%	-
Return on Capital (ROIC)	-26.14%	-26.14%	-21.81%	-37.10%	-27.47%	-24.03%	23.68%	25.88%
Earnings Yield	-7.33%	-11.67%	-2.73%	-3.35%	-2.21%	-4.21%	-	-
FCF Yield	-4.41%	-7.01%	-1.87%	-2.94%	-2.01%	-2.42%	-	-
Buyback Yield / Dilution	-8.47%	-8.47%	-3.29%	-5.07%	-43.60%	-2289.13%	-121.32%	-
Total Shareholder Return	-8.47%	-8.47%	-3.29%	-5.07%	-43.60%	-2289.13%	-121.32%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).